Search

Author/Creator Daniele, B.

1. D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. (26th September 2015)

Authors:
Cecere, S.C.; Daniele, G.; Lorusso, D.; Scambia, G.; Nicoletto, M.O.; Breda, E.; Colombo, N.; Artioli, G.; Daniele, B.; Lo Re, G.; Raspagliesi, F.; Chiappa, V.; Salutari, V.; Ferrandina, G.; Greggi, S.; Baldoni, A.; Piccirillo, M.C.; Fossati, R.; Perrone, F.; Pignata, S.
Journal:
Annals of oncology
Issue:
Volume 26(2015)Supplement 6
Page Start:
vi33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer. Issue 4 (July 2016)

Authors:
Di Bartolomeo, Maria; Pietrantonio, Filippo; Rulli, Eliana; Poli, Davide; Berenato, Rosa; Caporale, Marta; Bajetta, Emilio; Floriani, Irene; Bajetta, E.; Di Bartolomeo, M.; Catena, L.; Schiavo, M.; Pinotti, G.; Proserpio, I.; Rosati, G.; Bordonaro, R.; Cordio, S.; Burrafato, G.; Bochicchio, A.M.;...
Journal:
Tumori
Issue:
Volume 102:Issue 4(2016)
Page Start:
e15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. (March 2023)

Authors:
Sacco, R.; Ciruolo, M.; Paolillo, R.; Ramai, D.; Tortora, R.; Di, Costanzo G.G.; Burlone, M.; Pirisi, M.; Federico, P.; Daniele, B.; Silletta, M.; Gallo, P.; Cocuzza, C.; Russello, M.; Cabibbo, G.; Cesario, S.; Masi, G.; Marzi, L.; Mega, A.; Granito, A.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 2
Page Start:
S119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. (May 2021)

Authors:
Rosati, Gerardo; Lonardi, Sara; Galli, Fabio; Di Bartolomeo, Maria; Ronzoni, Monica; Zampino, Maria G.; Banzi, Maria; Zaniboni, Alberto; Pasini, Felice; Bozzarelli, Silvia; Garattini, Silvio K.; Ferrari, Daris; Montesarchio, Vincenzo; Mambrini, Andrea; Ciuffreda, Libero; Galli, Francesca; Puscedd...
Journal:
European journal of cancer
Issue:
Volume 148(2021)
Page Start:
190
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors. (March 2021)

Authors:
Tovoli, F.; Dadduzio, V.; De Lorenzo, S.; Rimassa, L.; Masi, G.; Iavarone, M.; Marra, F.; Garajova, I.; Brizzi, M.P.; Daniele, B.; Trevisani, F.; Messina, C.; Clemente, F. Di; Pini, S.; Cabibbo, G.; Granito, A.; Rizzato, M.D.; Zagonel, V.; Brandi, G.; Pressiani, T.
Journal:
Digestive and liver disease
Issue:
Volume 53:(2021)Supplement 1
Page Start:
S10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC). (10th February 2016)

Authors:
Di Costanzo, G.G.; D'Angelo, S.; Zolfino, T.; Lorusso, V.; Montesarchio, V.; de Stefano, G.; Sacco, R.; Attili, A.F.; Benedetti, A.; Sansonno, D.; Giannitrapani, L.; Buonadonna, A.; Giovanis, P.; Cabibbo, G.; De Vita, F.; Carucci, P.; Pirisi, M.; Moscovici, M.; Pisconti, S.; Daniele, B.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗